A carregar...
CSPG4 As a Target of Antibody-Based Immunotherapy For Malignant Mesothelioma
PURPOSE: Malignant mesothelioma (MM) is an aggressive cancer, resistant to current therapies. Membrane Chondroitin Sulphate Proteoglycan 4 (CSPG4), which has been successfully targeted in melanoma and breast cancer, was found highly expressed in MM, but not in normal mesothelium. Therefore, we explo...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3463742/ https://ncbi.nlm.nih.gov/pubmed/22893632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-0628 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|